CIS: Antisera Market 2023

Antisera Market Size in CIS

In 2022, the CIS antisera market decreased by X% to $X, falling for the second year in a row after five years of growth. Overall, consumption recorded a relatively flat trend pattern. As a result, consumption attained the peak level of $X. From 2021 to 2022, the growth of the market remained at a somewhat lower figure.

Antisera Production in CIS

In value terms, antisera production rose slightly to $X in 2022 estimated in export price. The total output value increased at an average annual rate of X% from 2012 to 2022; the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The growth pace was the most rapid in 2013 with an increase of X%. Over the period under review, production hit record highs at $X in 2020; afterwards, it flattened through to 2022.

Antisera Exports

Exports in CIS

In 2022, approx. X tons of antisera and other blood fractions were exported in the CIS; declining by X% against the previous year. Over the period under review, exports recorded a abrupt contraction. The growth pace was the most rapid in 2021 with an increase of X%. As a result, the exports attained the peak of X tons, and then shrank sharply in the following year.

In value terms, antisera exports contracted sharply to $X in 2022. In general, exports saw a abrupt contraction. The growth pace was the most rapid in 2021 with an increase of X% against the previous year. As a result, the exports attained the peak of $X, and then fell sharply in the following year.

Exports by Country

In 2022, Azerbaijan (X tons), distantly followed by Russia (X tons) and Armenia (X tons) were the major exporters of antisera and other blood fractions, together comprising X% of total exports. Moldova (X tons) held a relatively small share of total exports.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the leading exporting countries, was attained by Azerbaijan (with a CAGR of X%), while the other leaders experienced more modest paces of growth.

In value terms, Russia ($X) remains the largest antisera supplier in the CIS, comprising X% of total exports. The second position in the ranking was taken by Armenia ($X), with a X% share of total exports. It was followed by Azerbaijan, with an X% share.

In Russia, antisera exports decreased by an average annual rate of X% over the period from 2012-2022. In the other countries, the average annual rates were as follows: Armenia (X% per year) and Azerbaijan (X% per year).

Export Prices by Country

In 2022, the export price in the CIS amounted to $X per ton, with a decrease of X% against the previous year. Overall, the export price recorded a pronounced contraction. The most prominent rate of growth was recorded in 2014 an increase of X%. As a result, the export price attained the peak level of $X per ton. From 2015 to 2022, the export prices failed to regain momentum.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Russia ($X per ton), while Azerbaijan ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Moldova (X%), while the other leaders experienced mixed trends in the export price figures.

Antisera Imports

Imports in CIS

In 2022, purchases abroad of antisera and other blood fractions decreased by X% to X tons, falling for the second consecutive year after five years of growth. In general, imports continue to indicate a abrupt decrease. The most prominent rate of growth was recorded in 2020 when imports increased by X%. As a result, imports attained the peak of X tons. From 2021 to 2022, the growth of imports failed to regain momentum.

In value terms, antisera imports fell dramatically to $X in 2022. Over the period under review, imports continue to indicate a deep reduction. The pace of growth appeared the most rapid in 2019 with an increase of X%. Over the period under review, imports hit record highs at $X in 2021, and then shrank sharply in the following year.

Imports by Country

Russia was the major importer of antisera and other blood fractions in the CIS, with the volume of imports recording X tons, which was approx. X% of total imports in 2022. It was distantly followed by Kazakhstan (X tons), Uzbekistan (X tons) and Azerbaijan (X tons), together comprising a X% share of total imports. The following importers - Kyrgyzstan (X tons), Armenia (X tons) and Tajikistan (X tons) - together made up X% of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the key importing countries, was attained by Uzbekistan (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, the largest antisera importing markets in the CIS were Russia ($X), Kazakhstan ($X) and Uzbekistan ($X), with a combined X% share of total imports.

Uzbekistan, with a CAGR of X%, recorded the highest rates of growth with regard to the value of imports, among the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the import price in the CIS amounted to $X per ton, shrinking by X% against the previous year. Over the period from 2012 to 2022, it increased at an average annual rate of X%. The most prominent rate of growth was recorded in 2021 an increase of X% against the previous year. As a result, import price attained the peak level of $X per ton, and then declined in the following year.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Kazakhstan ($X per ton), while Tajikistan ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Kyrgyzstan (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :